Document is current
Any future updates will be listed below
-
Authors
Seifalian, Amelia https://orcid.org/0000-0002-5794-6900
Al-Uloom, Tamara F. Mehdi Bahr
Seifalian, Nicholas
Digesu, Alex
Khullar, Vikram
- License Information
-
More Information
Article History
Received: 21 February 2025
Accepted: 10 September 2025
First Online: 9 October 2025
Declarations
:
: This study did not require ethical approval.
: Dr. Amelia Seifalian is a shareholder of company NanoRegMed Ltd which holds patent for Hastalex®. The other authors declare no conflicts of interest, including any potential commercial interests.
